| Guidelines for the use and interpretation of assays for monitoring autophagy DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 13776* | 2021 |
| Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis JA Menendez, R Lupu Nature Reviews Cancer 7 (10), 763-777, 2007 | 3223 | 2007 |
| Olive oil and health: summary of the II international conference on olive oil and health consensus report, Jaén and Córdoba (Spain) 2008 J López-Miranda, F Pérez-Jiménez, E Ros, R De Caterina, L Badimón, ... Nutrition, metabolism and cardiovascular diseases 20 (4), 284-294, 2010 | 758 | 2010 |
| Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells JA Menendez, L Vellon, I Mehmi, BP Oza, S Ropero, R Colomer, R Lupu Proceedings of the National Academy of Sciences 101 (29), 10715-10720, 2004 | 425 | 2004 |
| STAT3 labels a subpopulation of reactive astrocytes required for brain metastasis N Priego, L Zhu, C Monteiro, M Mulders, D Wasilewski, W Bindeman, ... Nature Medicine 24 (7), 1024-1035, 2018 | 392 | 2018 |
| Metformin: multi-faceted protection against cancer S Del Barco, A Vazquez-Martin, S Cufí, C Oliveras-Ferraros, ... Oncotarget 2 (12), 896, 2011 | 392 | 2011 |
| The antidiabetic drug metformin suppresses HER2 (erbB-2) oncoprotein overexpression via inhibition of the mTOR effector p70S6K1 in human breast carcinoma cells A Vazquez-Martin, C Oliveras-Ferraros, JA Menendez Cell cycle 8 (1), 88-96, 2009 | 352 | 2009 |
| Oleic acid, the main monounsaturated fatty acid of olive oil, suppresses Her-2/neu (erbB-2) expression and synergistically enhances the growth inhibitory effects of trastuzumab … JA Menendez, L Vellon, R Colomer, R Lupu Annals of oncology 16 (3), 359-371, 2005 | 350 | 2005 |
| Autophagy in stem cells JL Guan, AK Simon, M Prescott, JA Menendez, F Liu, F Wang, C Wang, ... Autophagy 9 (6), 830-849, 2013 | 323 | 2013 |
| Autophagy facilitates the development of breast cancer resistance to the anti-HER2 monoclonal antibody trastuzumab A Vazquez-Martin, C Oliveras-Ferraros, JA Menendez PloS one 4 (7), e6251, 2009 | 299 | 2009 |
| Metformin and cancer: doses, mechanisms and the dandelion and hormetic phenomena B Martin-Castillo, A Vazquez-Martin, C Oliveras-Ferraros, JA Menendez Cell cycle 9 (6), 1057-1064, 2010 | 290 | 2010 |
| Fatty acid synthase (FASN) as a therapeutic target in breast cancer JA Menendez, R Lupu Expert opinion on therapeutic targets 21 (11), 1001-1016, 2017 | 271 | 2017 |
| Metformin against TGFβ-induced epithelial-to-mesenchymal transition (EMT): from cancer stem cells to aging-associated fibrosis S Cufi, A Vazquez-Martin, C Oliveras-Ferraros, B Martin-Castillo, J Joven, ... Cell cycle 9 (22), 4461-4468, 2010 | 270 | 2010 |
| Metformin regulates breast cancer stem cello ntogeny by transcriptional regulation of the epithelial-mesenchymal transition (EMT) status A Vazquez-Martin, C Oliveras-Ferraros, S Cufí, S Del Barco, ... Cell cycle 9 (18), 3831-3838, 2010 | 253 | 2010 |
| Mammosphere formation in breast carcinoma cell lines depends upon expression of E-cadherin J Manuel Iglesias, I Beloqui, F Garcia-Garcia, O Leis, A Vazquez-Martin, ... PloS one 8 (10), e77281, 2013 | 246 | 2013 |
| Fatty acid synthase: association with insulin resistance, type 2 diabetes, and cancer JA Menendez, A Vazquez-Martin, FJ Ortega, JM Fernandez-Real Clinical chemistry 55 (3), 425-438, 2009 | 243 | 2009 |
| Pharmacological inhibitors of fatty acid synthase (FASN)-catalyzed endogenous fatty acid biogenesis: a new family of anti-cancer agents? R Lupu, JA Menendez Current pharmaceutical biotechnology 7 (6), 483-494, 2006 | 241 | 2006 |
| Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells A Vazquez‐Martin, R Colomer, J Brunet, R Lupu, JA Menendez Cell proliferation 41 (1), 59-85, 2008 | 239 | 2008 |
| Olive oil's bitter principle reverses acquired autoresistance to trastuzumab (Herceptin™) in HER2-overexpressing breast cancer cells JA Menendez, A Vazquez-Martin, R Colomer, J Brunet, ... BMC cancer 7, 1-19, 2007 | 237 | 2007 |
| The anti-diabetic drug metformin suppresses self-renewal and proliferation of trastuzumab-resistant tumor-initiating breast cancer stem cells A Vazquez-Martin, C Oliveras-Ferraros, SD Barco, B Martin-Castillo, ... Breast cancer research and treatment 126, 355-364, 2011 | 222 | 2011 |
Alejandro Vazquez-MartinPost-doctoral researcherEmail verificata su iconcologia.net